Vergent Bioscience

Minneapolis, MN · Founded 2013 · Privately Held (backing)

Developer of molecular imaging probes designed for the diagnosis and removal of cancer cells. Vergent Bioscience is based in Minneapolis, MN and was founded in 2013. It was valued at $75 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $56.4 million across 5 recorded rounds; the latest was an $18.7 million early-stage round in Oct 2025.

PMV mark · valuation
$75.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$56.4M
Last round
Early Stage VC
Oct 2025

Who backs Vergent Bioscience?

7 investors
InvestorType
National Institutes of HealthOther
Spring Mountain CapitalGrowth equity
Colle Capital Partners—
Intuitive Surgical—
Orlando Health Ventures—
Rex Health Ventures—
Windham Capital Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vergent Bioscience investors

7 investors are on record for Vergent Bioscience, including National Institutes of Health, Spring Mountain Capital, Colle Capital Partners and Intuitive Surgical. The early-stage round in Oct 2025 drew 20 investors.

Free account
More of Vergent Bioscience with a free account
  • ·Watch Vergent Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Vergent Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View